Quiz: Fertility Preservation Possible in Stage I Ovarian Cancer?

What are secondary adjuvant therapy options for stages II–IV ovarian cancer patients in complete remission? And do you know if fertility preservation is possible in patients with stage I ovarian cancer? Test your knowledge on these topics and more in our latest quiz.

Question 1

Answer

B. 1.3%. According to the National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER) Program data, approximately 1.3% of women will be diagnosed with ovarian cancer at some point during their lifetime.

Question 2

Answer

B.22,440. According to SEER Program data, an estimated 22,440 women will be newly diagnosed with ovarian cancer in 2017.

Question 3

Answer

A.True. According to the National Comprehensive Cancer Network (NCCN) 2017 Guidelines, if fertility preservation is desired, clinical stage IA ovarian cancer should be treated with unilateral salpingo-oophorectomy plus comprehensive surgical staging, and clinical stage IB disease should be treated with bilateral salpingo-oophorectomy plus comprehensive surgical staging.

Question 4

Answer

B.39%. According to the most recent estimates by the National Cancer Institute, 39% of women who inherit a BRCA1 mutation and 11% to 17% of women who inherit a BRCA2 mutation will develop ovarian cancer by 70 years of age.

Question 5

Answer

D.Carboplatin. According to the NCCN 2017 Guidelines, secondary adjuvant therapy options include clinical trials, observation with follow-up monitoring, and treatment with pazopanib.